Design of tuberculosis vaccine trials under financial constraints

Expert Rev Vaccines. 2016 Jul;15(7):799-801. doi: 10.1080/14760584.2016.1178067. Epub 2016 May 9.

Alberto L García-Basteiro^{1

2

3}, Morten Ruhwald⁴, Christoph Lange^{5

6

7

8

9}

¹ a Centro de Investigação em Saúde de Manhiça (CISM) , Maputo , Mozambique.
² b ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB) , Hospital Clínic - Universitat de Barcelona , Barcelona , Spain.
³ c Amsterdam Institute for Global Health and Development (AIGHD) , Amsterdam , The Netherlands.
⁴ d Human immunology, Dept. of infectious disease immunology , Statens Serum Institut , Copenhagen , Denmark.
⁵ e Division of Clinical Infectious Diseases , Research Center Borstel , Borstel , Germany.
⁶ f German Center for Infection Research , Clinical Tuberculosis Center , Borstel , Germany.
⁷ g International Health/Infectious Diseases , University of Lübeck , Lübeck , Germany.
⁸ h Department of Medicine , Karolinska Institute , Stockholm , Sweden.
⁹ i Department of Internal Medicine , University of Namibia School of Medicine , Windhoek , Namibia.

No abstract available

Keywords: BCG; R&D; Tuberculosis; correlates of protection; vaccine.

Publication types